Can a smartphone app help young cancer survivors stay on track?
NCT ID NCT03363711
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a mobile app designed to help adolescent and young adult cancer survivors follow their personalized care plans. 25 survivors aged 15-29 who have finished cancer treatment will use the app to receive tailored text messages and educational content. The goal is to see if the app is easy to use and encourages survivors to take charge of their health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mobile health application (AYA STEPS)
What this could lead to
If it works, this could point toward a simple, scalable way to help young cancer survivors stick to their follow-up care plans.
What could go wrong
This is a very small, early-stage study (25 people) focused on feasibility, not on health outcomes. The app may not improve care plan adherence in a larger, more diverse group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States